Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Invested Capital (2016 - 2025)

Integra Lifesciences Holdings' Return on Invested Capital history spans 16 years, with the latest figure at 0.26% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 26.0% year-over-year to 0.26%; the TTM value through Dec 2025 reached 0.26%, down 26.0%, while the annual FY2025 figure was 0.22%, 23.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.26% at Integra Lifesciences Holdings, down from 0.25% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.08% in Q2 2021 and bottomed at 0.26% in Q4 2025.
  • The 5-year median for Return on Invested Capital is 0.06% (2021), against an average of 0.01%.
  • The largest annual shift saw Return on Invested Capital increased 9bps in 2021 before it decreased -26bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.06% in 2021, then rose by 27bps to 0.08% in 2022, then plummeted by -50bps to 0.04% in 2023, then plummeted by -88bps to 0.0% in 2024, then plummeted by -5518bps to 0.26% in 2025.
  • Per Business Quant, the three most recent readings for IART's Return on Invested Capital are 0.26% (Q4 2025), 0.25% (Q3 2025), and 0.22% (Q2 2025).